Pnc Financial Services »

Cyclerion Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2024-06-30 $5 2 2.50

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Erie Indty Cl A (ERIE)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Wisdomtree Tr Us Qtly Div Gr (DGRW)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Ishares Tr Msci Usa Qlt F (QUAL)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Ishares Tr Msci Intl Qual (IQLT)

View all positions for Pnc Financial Services

Top funds holding Cyclerion Therapeutics

Slate Path Capital
MFN Partners Management
Tyndall Capital Partners
Artal Group
Geode Capital Management
Vanguard Group
BlackRock
Tower Research Capital
Morgan Stanley
Group One Trading
Royal Bank of Canada
Activest Wealth Management
Bank of America Corporation
Pnc Financial Services
Northwestern Mutual Wealth Management Company

View all funds holding Cyclerion Therapeutics